Conditions

Non-alcoholic fatty liver disease (NAFLD) is a common condition that affects millions of people around the world. It occurs when fat builds up in the liver, causing inflammation and scarring. NAFLD is closely linked to type 2 diabetes, which is a chronic condition characterized by elevated blood sugar levels due to …

Recent Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes have been established to help control the risks associated with this chronic condition. These guidelines are focused on reducing the risk of heart attack, stroke, and other cardiovascular diseases (CVDs) through lifestyle changes and medications. The American Diabetes …

Insulin sensitivity is an important factor in the management of diabetes, as it affects how well your body can use insulin to make glucose available to cells for energy. Improving insulin sensitivity is an important goal for people with diabetes, and researchers are continually looking for new ways to do …

Bisphenol A (BPA) is an industrial chemical that is widely used in the production of plastic products and food packaging materials. Despite its widespread use, recent research has suggested that BPA exposure may be associated with an increased risk of developing type 2 diabetes. Type 2 diabetes is a chronic …

Type 2 diabetes is a growing health concern among older adults, with an estimated 29 million individuals over the age of 65 in the United States alone being diagnosed with the condition. While type 2 diabetes can affect people of all ages, it is particularly prevalent among older adults due …

Now that 2022 is behind us, Diabetes in Control presents our top 5 viewed articles from the year. Delve into this content to learn more about diabetes, its effects on individuals with the condition, and a revolutionary treatment breakthrough. #1 The impact of health coaching with family support on patient …

Authors: Ashley Wagnild, PharmD Candidate 2024, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 54-year-old man was referred to the pharmacotherapy clinic by his primary care provider (PCP) for a therapy consult. The patient had a past medical …

Recently, the United States Food and Drug Administration granted approval for Tzield (teplizumab-mzwv) injection: a groundbreaking treatment intended to obstruct the progression of stage 2 type 1 diabetes into its more serious form in adults as well as pediatric patients who are 8 years or older. John Sharretts, M.D., director …

Sponsored Content  Bromocriptine-QR (Cycloset) “is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mechanisms.” This study investigated the impact of Cycloset on the pro-inflammatory state …

No specific approach is used currently but which one is better? Every year, 2% to 10% of pregnant women are diagnosed with gestational diabetes. Gestational diabetes is a type of diabetes that develops in pregnant women who did not have diabetes before they got pregnant. Some causes or risk factors …